Call Us: (513) 621-5112

 
 
 
 
 
 
Sterling Research Blog
 
Monoclonal Antibodies Revolutionizing Patient Care
Friday, August 15, 2014

Monoclonal antibodies are revolutionizing patient care. They give us the ability to target very specific proteins in the human body. Currently at Sterling Research we are conducting studies with monoclonal antibodies for patients with high cholesterol, rheumatoid arthritis, and diabetic kidney disease. With the help of volunteers, the future of medicine looks bright!

-Dr. Wenker



 
 
Subscribe To Our Blog

Blog Categories

  • Articles
    • 03/23/2017 - New Drug Prevents Heart Attack
    • 06/07/2016 - Meningitis: More than just a “
    • 02/29/2016 - One Decade Later, HPV Vaccine
    • 05/22/2015 - The Truth About Insulin
    • 05/22/2015 - Diabetes Clinical Research
    • 05/12/2015 - Osteoarthritis
    • 05/04/2015 - What can I do about Acne?
    • 02/18/2015 - Yet Another "Cutting Edge" Med
    • 01/26/2015 - Recent study of an investigati
    • 12/03/2014 - It Is Estimated That 1 in 3 Am
    • 12/02/2014 - Making a positive impact on th
    • 10/28/2014 - Happy Birthday wishes to Dr. J
    • 08/15/2014 - Monoclonal Antibodies Revoluti
    • 07/09/2013 - Swimmer's Ear - What You Need
    • 05/17/2013 - Pink Eye: Usually Mild and Eas
    • 05/05/2013 - High Triglycerides - What You
    • 03/13/2013 - UK Researchers Dispel Myths of
    • 06/14/2012 - Why Do Research In Children?
    • 01/13/2010 - Should Your Child Be in a Clin
    • 05/09/2008 - Med Hero Campaign TV Spot
  • News

Tag Cloud
 
 
 

CONTACT US
NEWS & ARTICLES
Call For Participation
Patient Recruitment Specialist
Cincinnati, OH

PH: (513) 621-5112
FX:  (513) 621-5101

Cincinnati / Mt. Auburn
2230 Auburn Avenue
Level B
Cincinnati, OH 45219
PH: (513) 381-4100
FX:  (513) 381-4120

Springdale
375 Glensprings Drive
2nd Floor
Cincinnati, OH 45246
PH: (513) 671-8080
FX:  (513) 671-8090
New Drug Prevents Heart Attacks in High-Risk Patients
Thursday, March 23, 2017

A new heart drug cuts cholesterol levels to once unthinkable lows, a treatment that doctors hope may prevent future heart attacks or stroke in high-risk patients, according to results from a highly anticipated study released Friday.

 
 
 



Copyright © 2017. STERLING RESEARCH. All Rights Reserved